Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B study

Authors: Mohummad A. Rahman, Jorunn Brekke, Victoria Arnesen, Marianne H. Hannisdal, Andrea G. Navarro, Andreas Waha, Lars Herfindal, Cecilie B. Rygh, Eirik Bratland, Petter Brandal, Judit Haasz, Leif Oltedal, Hrvoje Miletic, Arvid Lundervold, Stein A. Lie, Dorota Goplen, Martha Chekenya

Source: Immunity, Inflammation and Disease, Vol 8, Iss 3, Pp 342-359 (2020)

Subject Terms: bortezomib, immune checkpoint, MGMT, recurrent GBM, temozolomide, Th1/Th2 cytokine ratios, Immunologic diseases. Allergy, RC581-607

File Description: electronic resource

Relation: https://doaj.org/toc/2050-4527

Access URL: https://doaj.org/article/6667890c0064459f9f27a9dbdca009cb